217–224 (2007)ĭavis, M.I., Hunt, J.P., Herrgard, S., Ciceri, P., Wodicka, L.M., Pallares, G., Hocker, M., Treiber, D.K., Zarrinkar, P.P.: Comprehensive analysis of kinase inhibitor selectivity. In: Proceedings of the 24th International Conference on Machine Learning, pp. 8(5), e1002503 (2012)ĭavis, J., Santos Costa, V., Ray, S., Page, D.: An integrated approach to feature invention and model construction for drug activity prediction. 25(1), 71–75 (2007)Ĭheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., Tang, Y.: Prediction of drug-target interactions and drug repositioning via network-based inference. 8(7), 1970–1978 (2012)Ĭheng, A.C., Coleman, R.G., Smyth, K.T., Cao, Q., Soulard, P., Caffrey, D.R., Salzberg, A.C., Huang, E.S.: Structure-based maximal affinity model predicts small-molecule druggability.

Ĭhen, X., Liu, M.X., Yan, G.Y.: Drug-target interaction prediction by random walk on the heterogeneous network. 86, 250–260 (2015)Ĭellier, P., Charnois, T., Plantevit, M.: Sequential patterns to discover and characterise biological relations. 52, 25–36 (2016)īuza, K., Nanopoulos, A., Nagy, G.: Nearest neighbor regression in the presence of bad hubs. Bioinformatics 25(18), 2397–2403 (2009)īolgar, B., Antal, P.: Bayesian matrix factorization with non-random missing data using informative Gaussian process priors and soft evidences. 11, 687–712 (2010)īleakley, K., Yamanishi, Y.: Supervised prediction of drug-target interactions using bipartite local models. īiau, G., Cérou, F., Guyader, A.: On the rate of convergence of the bagged nearest neighbor estimate. In: 4th International Conference on Data Mining in Bioinformatics, pp. 12(1), 56–68 (2011)īesemann, C., Denton, A., Yekkirala, A.: Differential association rule mining for the study of protein-protein interaction networks. Supplementary material is available at: Keywordsīarabási, A.L., Gulbahce, N., Loscalzo, J.: Network medicine: a network-based approach to human disease. The results show that our approach statistically significantly outperforms BLM-NII, a recent version of BLM, as well as NetLapRLS and WNN-GIP.Ĭode related to this chapter is available at: ĭata related to this chapter are available at: Our technique (ALADIN) is evaluated on publicly available real-world drug–target interaction datasets. Additionally, we propose to build a projection-based ensemble. In this paper, we extend BLM by the incorporation of a hubness-aware regression technique coupled with an enhanced representation of drugs and targets in a multi-modal similarity space. State-of-the-art approaches are based on various techniques, such as matrix factorization, restricted Boltzmann machines, network-based inference and bipartite local models (BLM). Due to its pharmaceutical applications, one of the most prominent machine learning challenges in bioinformatics is the prediction of drug–target interactions.

Aladin 2009 running time